GE HealthCare launched Invenia ABUS (Automated Breast Ultrasound) Prime, an AI-powered ultrasound for dense breast tissue, alongside ABUS StreamVue, a browser-based platform for remote image review.
While 40% of women have dense breasts – making them 4 to 6 times more likely to develop cancer – screening solutions have been limited. Mammograms struggle to distinguish dense tissue from tumors, leaving traditional ultrasounds as the mainstream alternative.
Since 2024, the FDA has required mammography providers to notify patients if they have dense breasts and explain that supplemental screening may be beneficial. Additionally, the Health Resources and Services Administration’s (HRSA) latest guidelines mandate coverage for supplemental screening across most private plans, while the proposed Find It Early Act would extend to Medicare, Medicaid, and TRICARE.
GE HealthCare’s latest solution revamps the current offering. Invenia ABUS Prime, which is FDA Premarket Approved, employs automated 3D ultrasound imaging, rapid scan technology, and AI-assisted quality checks, while FDA-cleared StreamVue powers remote readings across imaging networks.
“Invenia ABUS Prime builds on our commitment to advancing supplemental breast screening for women with dense breasts,” said Karley Yoder, CEO, Ultrasound Solutions, Advanced Imaging Solutions, GE HealthCare. “As breast imaging networks look to scale across sites, Invenia ABUS Prime can help deliver streamlined workflows, reproducible imaging, with features designed to support both patient comfort and clinician efficiency.”
To establish Prime and StreamVue into clinic protocols, GE HealthCare has teamed up with Los Angeles-based breast imaging center BeSound to roll out the tech.
“At BeSound, our mission is to make supplemental breast screening more accessible and more convenient for the women who need it,” said Bailey Renger, Founder and CEO, BeSound. “With Invenia ABUS Prime, we hope to expand access to advanced breast imaging in a way that is patient-centered and meets women where they are.”
GE joins a growing group of companies advancing supplemental dense breast screening, including Delphinus and iSono Health, as new screening requirements and reimbursement policies continue to improve breast imaging.
